Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review - Top-Institutions - MDSpire

Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review

  • By

  • Mai A. Elkalla

  • Yousef G. Ali

  • Mohamed M. Ewais

  • Ahmed S. Taha

  • Mohab Sherif

  • December 22, 2025

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Pain Medicine

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Neurogastroenterology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Neuroscience

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Pain Medicine

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Neurogastroenterology

Original Source(s)

Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review

  • by Mai A. Elkalla, Yousef G. Ali, Mohamed M. Ewais, Ahmed S. Taha, Mohab Sherif

  • December 22, 2025

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Kinesio Taping Shows Limited, Uncertain Benefits

Researchers find effects vary by timing, comparator, and outcome across musculoskeletal disorders

Microglial CX3CR1 signaling mediates stress-induced pain behavior in mice